Gordon Naylor — SPARQNOW

At-a-Glance

CEO and Managing Director of CSL, a global biotechnology leader
Serves as Non Executive Director for Orica, Medical Developments International, Celleo Biotech, and Whitelion
Led a three-year turnaround as President of Seqirus, positioning it as a global influenza vaccines leader
Career spans advanced manufacturing, global supply chain, IT, and major infrastructure projects
Over 33 years with CSL, starting as an engineer in the late 1980s

Biography

Gordon Naylor serves as the CEO and Managing Director of CSL, a global biotechnology leader dedicated to improving public health through plasma-derived therapies, innovative medicines for rare diseases, and influenza vaccines. He has a long association with CSL, having started his career as an engineer in the late 1980s and contributing to the company's transformation from a domestic manufacturer into a global biotechnology leader.